Log in with your email address username.


Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Department of Error] Department of Error

Cox TM, Drelichman G, Cravo R, et al. Eliglustat compared with imiglucerase in patients with Gaucher’s disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial. Lancet 2015; 385: 2355–62—In supplemental table C in the appendix, the first column and second row should have read “Imiglucerase (N=45)”, the third column and 11th row should have read “–0·10 (1·07)”, the second column and 12th row should have read “–0·47 (1·29)”, the third column and 13th row should have read “0·13 (1·03)”, and the second column and 14th row should have read “–0·18 (1·12)”.